WC
BMY icon

Whitnell & Co’s Bristol-Myers Squibb BMY Stock Holding History

Whitnell & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1.15M Buy
17,934
+4,103
+30% +$235K 0.35% 75
2019
Q3 		$701K Sell
13,831
-1,416
-9% -$66.5K 0.23% 94
2019
Q2 		$691K Buy
15,247
+6
+0% +$279 0.26% 85
2019
Q1 		$727K Sell
15,241
-2,870
-16% -$143K 0.28% 84
2018
Q4 		$941K Buy
18,111
+5
+0% +$269 0.42% 64
2018
Q3 		$1.12M Sell
18,106
-819
-4% -$48.6K 0.44% 62
2018
Q2 		$1.05M Sell
18,925
-3,996
-17% -$216K 0.44% 62
2018
Q1 		$1.45M Sell
22,921
-145
-0.6% -$9.33K 0.61% 51
2017
Q4 		$1.41M Sell
23,066
-296
-1% -$18.5K 0.59% 55
2017
Q3 		$1.49M Buy
23,362
+4
+0% +$234 0.65% 54
2017
Q2 		$1.3M Buy
23,358
+5
+0% +$272 0.58% 58
2017
Q1 		$1.27M Sell
23,353
-595
-2% -$32.6K 0.57% 57
2016
Q4 		$1.4M Buy
23,948
+6
+0% +$328 0.65% 50
2016
Q3 		$1.29M Sell
23,942
-698
-3% -$44.8K 0.44% 60
2016
Q2 		$1.81M Buy
24,640
+4
+0% +$283 0.59% 50
2016
Q1 		$1.57M Buy
24,636
+4
+0% +$252 0.59% 55
2015
Q4 		$1.69M Buy
24,632
+4
+0% +$264 0.64% 48
2015
Q3 		$1.46M Sell
24,628
-218
-0.9% -$13.8K 0.57% 53
2015
Q2 		$1.65M Buy
24,846
+5,224
+27% +$344K 0.6% 51
2015
Q1 		$1.27M Sell
19,622
-1,494
-7% -$93.5K 0.47% 58
2014
Q4 		$1.25M Buy
21,116
+454
+2% +$25.6K 0.47% 58
2014
Q3 		$1.06M Sell
20,662
-195
-0.9% -$9.74K 0.42% 59
2014
Q2 		$1.01M Sell
20,857
-1,144
-5% -$56.4K 0.46% 61
2014
Q1 		$1.14M Sell
22,001
-570
-3% -$30.3K 0.54% 58
2013
Q4 		$1.2M Sell
22,571
-4,237
-16% -$216K 0.55% 58
2013
Q3 		$1.24M Sell
26,808
-3,221
-11% -$141K 0.61% 53
2013
Q2 		$1.34M Buy
+30,029
New +$1.3M 0.67% 45

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Whitnell & Co's BMY Position: Q4 2019 in Review

Whitnell & Co increased its Bristol-Myers Squibb (BMY) stake by 30% in Q4 2019, buying an estimated $235K and bringing the position to 17,934 shares worth $1.15M. The position accounts for 0.35% of the portfolio, ranked #75.

Whitnell & Co first reported a position in BMY in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.81M in Q2 2016. 2,217 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Whitnell & Co held 17,934 shares of Bristol-Myers Squibb worth $1.15M as of Q4 2019.
  • Whitnell & Co bought 4,103 Bristol-Myers Squibb shares in Q4 2019, an estimated $235K.
  • Bristol-Myers Squibb made up 0.35% of Whitnell & Co's portfolio in Q4 2019, its #75 holding.
  • Whitnell & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 27 quarters since.
  • Whitnell & Co's Bristol-Myers Squibb position peaked at $1.81M in Q2 2016.
  • 2,217 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Whitnell & Co's 13F filing for Q4 2019, filed 11 Feb 2020.